- Home
- PHAT vs STAA Comparison
PHAT vs STAA Comparison
Compare PHAT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- STAA
- Stock Information
- Founded
- PHAT 2018
- STAA 1982
- Country
- PHAT United States
- STAA United States
- Employees
- PHAT N/A
- STAA N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- PHAT Health Care
- STAA Health Care
- Exchange
- PHAT Nasdaq
- STAA Nasdaq
- Market Cap
- PHAT 1.2B
- STAA 1.3B
- IPO Year
- PHAT 2019
- STAA N/A
- Fundamental
- Price
- PHAT $8.78
- STAA $26.66
- Analyst Decision
- PHAT Strong Buy
- STAA Buy
- Analyst Count
- PHAT 4
- STAA 7
- Target Price
- PHAT $22.50
- STAA $43.33
- AVG Volume (30 Days)
- PHAT 1.9M
- STAA 631.7K
- Earning Date
- PHAT 11-07-2024
- STAA 10-30-2024
- Dividend Yield
- PHAT N/A
- STAA N/A
- EPS Growth
- PHAT N/A
- STAA 9.97
- EPS
- PHAT N/A
- STAA 0.44
- Revenue
- PHAT $26,270,000.00
- STAA $341,224,000.00
- Revenue This Year
- PHAT $6,714.96
- STAA $8.45
- Revenue Next Year
- PHAT $293.69
- STAA $12.35
- P/E Ratio
- PHAT N/A
- STAA $60.61
- Revenue Growth
- PHAT N/A
- STAA 10.01
- 52 Week Low
- PHAT $6.07
- STAA $26.63
- 52 Week High
- PHAT $19.71
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- PHAT 23.73
- STAA 33.28
- Support Level
- PHAT $8.91
- STAA $29.56
- Resistance Level
- PHAT $19.05
- STAA $32.00
- Average True Range (ATR)
- PHAT 1.74
- STAA 1.58
- MACD
- PHAT -1.05
- STAA -0.22
- Stochastic Oscillator
- PHAT 2.19
- STAA 0.56
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.